Marks Group Wealth Management Inc Lowers Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Marks Group Wealth Management Inc lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,109 shares of the medical equipment provider’s stock after selling 82 shares during the period. Marks Group Wealth Management Inc’s holdings in Intuitive Surgical were worth $5,798,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in ISRG. Bennett Selby Investments LP raised its holdings in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after purchasing an additional 17 shares in the last quarter. LVW Advisors LLC raised its position in shares of Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after acquiring an additional 19 shares in the last quarter. Wesbanco Bank Inc. lifted its stake in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares during the last quarter. FSM Wealth Advisors LLC boosted its position in Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC grew its stake in Intuitive Surgical by 1.9% in the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock valued at $542,000 after purchasing an additional 19 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 in the last quarter. 0.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts have commented on the stock. Robert W. Baird increased their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Truist Financial increased their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Mizuho increased their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, Bernstein Bank upped their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $591.65 on Wednesday. The firm’s fifty day moving average is $555.91 and its two-hundred day moving average is $515.92. The firm has a market cap of $210.73 billion, a price-to-earnings ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.